Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Exchange Rate Effect (2018 - 2025)

Historic Exchange Rate Effect for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$1.2 million.

  • Bicycle Therapeutics' Exchange Rate Effect fell 17368.73% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$755000.0, marking a year-over-year decrease of 13177.61%. This contributed to the annual value of -$694000.0 for FY2024, which is 15156.02% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Exchange Rate Effect stood at -$1.2 million for Q3 2025, which was down 17368.73% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Exchange Rate Effect peaked at $3.6 million during Q4 2022, and registered a low of -$2.6 million during Q3 2022.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$174000.0 (2021), whereas its average is -$34368.4.
  • Within the past 5 years, the most significant YoY rise in Bicycle Therapeutics' Exchange Rate Effect was 5933333.33% (2022), while the steepest drop was 74310.34% (2022).
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Exchange Rate Effect stood at -$6000.0 in 2021, then skyrocketed by 59333.33% to $3.6 million in 2022, then crashed by 63.73% to $1.3 million in 2023, then tumbled by 238.17% to -$1.8 million in 2024, then increased by 29.87% to -$1.2 million in 2025.
  • Its Exchange Rate Effect stands at -$1.2 million for Q3 2025, versus $1.8 million for Q2 2025 and $468000.0 for Q1 2025.